Author

Esther Pérez‐Herrán

GlaxoSmithKline (Spain)ORCID 0000-0002-4464-9528Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Organism:human· 1

Frequent Co-Authors

Alexandre López· 1 shared Alfonso Mendoza-LosanaiD· 1 shared Alfonso Toro-CórdovaiD· 1 shared Álvaro PeñaiD· 1 shared Ana Gallego-Lleyda· 1 shared Ángel Santos-Villarejo· 1 shared Beatriz Blandín· 1 shared Charles J. ThompsoniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alexandre López

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multicomponent Thiolactone-Based Ionizable Lipid Screening Platform for an Efficient and Tunable mRNA Delivery to the Lungs

Álvaro Peña, Juan Heredero, Beatriz Blandín, Elena Mata, Diego de Miguel, Alfonso Toro-Córdova, Teresa Alejo, Diego Casabona, Alexandre López, Ana Gallego-Lleyda, Esther Pérez‐Herrán, Juan Martínez-Oliván, Javier Giménez-Warren

This paper develops a lipid screening platform to identify efficient and tunable ionizable lipids for mRNA delivery to the lungs, resulting in a lipid that enhances protein expression and shows selective lung targeting.

Communications Chemistry · Apr 15, 2025Peer-reviewedBiochemistry

Sanfetrinem, an oral beta-lactam antibiotic repurposed for the treatment of tuberculosis

Santiago Ramón‐García, Rubén González del Río, María Pilar Arenaz-Callao, Helena I. Boshoff, Joaquín Rullás, Sara Anca, Mónica Cacho, Esther Porras de Francisco, Esther Pérez‐Herrán, Ángel Santos-Villarejo, Alfonso Mendoza-Losana, Santiago B. Ferrer, Charles J. Thompson, David Barros-Aguirre, Robert H. Bates

This paper identifies sanfetrinem cilexetil as a promising oral beta-lactam antibiotic for tuberculosis treatment through preclinical studies showing its activity against Mtb and potential for repurposing.

Drug Resistance Updates · Feb 15, 2025Peer-reviewedMicrobiology